ELV
Elevance Health Inc.
Price performance
Sep 18, 2026About
Company activity
32 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 09/10 | ELV | 8-K | Elevance Health Reaffirms 2026 Earnings Guidance | — | — | — |
| 07/15 | ELV | 8-K | Elevance Health Reports Strong Q2 2026 Results and Raises Full-Year Guidance | — | — | — |
| 06/10 | ELV | 8-K | Elevance Health Reaffirms 2026 Earnings Guidance | — | — | — |
| 05/13 | ELV | 8-K | Elevance Health, Inc. Announces Election of Directors at Annual Meeting | — | — | — |
| 04/22 | ELV | 8-K | Elevance Health Reports Q1 2026 Results and Raises Guidance | — | — | — |
| 03/10 | ELV | 8-K | Elevance Health, Inc. to Face CMS Sanctions and Reaffirms Financial Guidance | — | — | — |
| 03/02 | ELV | 8-K | Elevance Health Faces Potential Medicare Sanctions | — | — | — |
| 02/26 | ELV | 8-K | Elevance Health Announces Significant Management Changes | — | — | — |
| 01/28 | ELV | 8-K | Elevance Health Reports 2025 Financial Results and 2026 Outlook | — | — | — |
| 12/10/25 | ELV | 8-K | Election of Amy W. Schulman as New Independent Director | — | — | — |
| 11/10/25 | ELV | 8-K | Elevance Health Reaffirms 2025 Earnings Guidance | — | — | — |
| 10/21/25 | ELV | 8-K | Elevance Health Reports Third Quarter 2025 Earnings | — | — | — |
| 09/15/25 | ELV | 8-K | Elevance Health, Inc. Completes $2.97 Billion Notes Offering | — | — | — |
| 09/04/25 | ELV | 8-K | Elevance Health Reaffirms 2025 Earnings Guidance | — | — | — |
| 07/28/25 | ELV | 8-K | Elevance Health Appoints Steven H. Collis to Board of Directors | — | — | — |
| 07/17/25 | ELV | 8-K | Elevance Health Reports 2Q 2025 Financial Results | — | — | — |
| 05/28/25 | ELV | 8-K | Elevance Health Reaffirms 2025 Earnings Guidance | — | — | — |
| 05/14/25 | ELV | 8-K | Elevance Health, Inc. Announces Results of Annual Shareholder Meeting | — | — | — |
| 04/22/25 | ELV | 8-K | Elevance Health Reports Strong Q1 2025 Financial Results | — | — | — |
| 04/17/25 | ELV | 8-K | Elevance Health Announces First Quarter 2025 Financial Results and Outlook | — | — | — |
| 03/10/25 | ELV | 8-K | Elevance Health Reaffirms 2025 Earnings Guidance | — | — | — |
| 01/23/25 | ELV | 8-K | Elevance Health Reports Fourth Quarter and Full Year 2024 Financial Results | — | — | — |
| 10/31/24 | ELV | 8-K | Elevance Health Closes $5.138 Billion Notes Offering | — | — | — |
| 10/17/24 | ELV | 8-K | Elevance Health Reports Q3 2024 Financial Results | — | — | — |
| 07/17/24 | ELV | 8-K | Elevance Health Reports 2Q 2024 Financial Results with EPS Increase | — | — | — |
| 06/12/24 | ELV | 8-K | Elevance Health Reaffirms Full Year 2024 Net Income Guidance | — | — | — |
| 05/30/24 | ELV | 8-K | Elevance Health, Inc. Completes $2.6 Billion Notes Offering | — | — | — |
| 05/15/24 | ELV | 8-K | Elevance Health, Inc. Announces Annual Shareholder Meeting Results | — | — | — |
| 04/18/24 | ELV | 8-K | Elevance Health Reports Q1 2024 Results and Raises Full-Year Guidance | — | — | — |
| 03/04/24 | ELV | 8-K | Elevance Health Reaffirms 2024 Net Income Guidance and Updates Star Ratings | — | — | — |
| 01/25/24 | ELV | 8-K | Elevance Health Announces Quarterly Dividend | — | — | — |
| 01/24/24 | ELV | 8-K | Elevance Health Reports Q4 2023 Results and Sets Outlook for 2024 | — | — | — |
ELV filing record
Elevance Health Inc. (ELV): 32 8-K filings summarized, the most recent on Sep 10, 2026.
What the 8-K filings said
- Sep 10, 2026 · low impact
Elevance Health, Inc. has reaffirmed its shareholders' earnings guidance for full year 2026 to be at least $20.10 per diluted share, including approximately $6.90 per diluted share of net unfavorable items. Excluding these items, the Company continues to expect adjusted shareholders' earnings to be at least $27.00 per…
Elevance Health Reaffirms 2026 Earnings Guidance - Jul 15, 2026 · high impact
Elevance Health, Inc. reported its financial results for the quarter ended June 30, 2026, with operating revenue of $49.8 billion, up 0.8% from the prior year quarter. The company reported diluted EPS of $6.71 and adjusted diluted EPS of $7.45, supported by favorable benefit expense performance and an approximately…
Elevance Health Reports Strong Q2 2026 Results and Raises Full-Year Guidance - Jun 10, 2026 · low impact
Elevance Health, Inc. has reaffirmed its shareholders' earnings guidance for full year 2026 to be at least $19.85 per diluted share, including approximately $6.90 per diluted share of net unfavorable items. Excluding these items, the Company continues to expect adjusted shareholders' earnings to be at least $26.75 per…
Elevance Health Reaffirms 2026 Earnings Guidance - May 13, 2026 · high impact
Elevance Health, Inc. held its Annual Meeting of Shareholders on May 13, 2026, where shareholders elected three directors to serve three-year terms. The advisory vote on the Company's executive compensation was approved, and the appointment of Ernst & Young LLP as the independent registered public accounting firm was…
Elevance Health, Inc. Announces Election of Directors at Annual Meeting - Apr 22, 2026 · high impact
Elevance Health, Inc. reported first quarter 2026 operating revenue of $49.5 billion, a 1.5% increase from Q1 2025. The company reported diluted EPS of $8.00 and adjusted diluted EPS of $12.58. Elevance Health raised its full-year 2026 guidance for both diluted EPS (to at least $19.85) and adjusted diluted EPS (to at…
Elevance Health Reports Q1 2026 Results and Raises Guidance
SEC filings in the last five years
- 52 Form 8-K
- 13 Form 10-Q
- 5 Form 10-K
- 1 Form 10-Q/A
- 1 Form 8-K/A